Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Proc Natl Acad Sci U S A, 2002
Shibata, N., Jishage, K., Arita, M., Watanabe, M., Kawase, Y., Nishikawa, K., Natori, Y., Inoue, H., Shimano, H., Yamada, N., Tsujimoto, M., & Arai, H
MECHANISMS OF ACTION OF GLP-1 RAs AND MULTI-AGONIST THERAPIES Incretin-based therapies leverage the physiological roles of gut-derived peptide hormones, principally glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor (GCG) to address the multifaceted pathophysiology of MASLD
The resulting hearing loss is typically transient and attributed to edema formation within the cochlear duct
US$ 29.47
US$ 24.97
US$ 23.40
US$ 22.83
US$ 27.65
US$ 23.73
US$ 21.50
US$ 21.36
US$ 22.85
US$ 23.60
US$ 26.60
US$ 20.91
